Felix Gutierrez
Overview
Explore the profile of Felix Gutierrez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
249
Citations
4680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izquierdo R, Rava M, Gutierrez F, Garcia-Fraile L, Riera M, Imaz A, et al.
AIDS
. 2025 Mar;
PMID: 40072419
Objective: We assessed the association between early HIV medical care interruption (MCI) and the development of AIDS-defining events (ADEs), serious non-AIDS events (SNAEs), and death among people with HIV (PWH)...
2.
Masia M, Gutierrez F
Enferm Infecc Microbiol Clin (Engl Ed)
. 2025 Mar;
43(3):123-124.
PMID: 40037742
No abstract available.
3.
Gutierrez F, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, Barrajon-Catalan E, Masia M
Clin Infect Dis
. 2024 Dec;
PMID: 39673180
No abstract available.
4.
Collins S, Shotwell M, Strich J, Gibbs K, de Wit M, Files D, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2448215.
PMID: 39625722
Importance: Fostamatinib, a spleen tyrosine kinase inhibitor, has been reported to improve outcomes of COVID-19. Objective: To evaluate the efficacy and safety of fostamatinib in adults hospitalized with COVID-19 and...
5.
Garcia-Abellan J, Garcia J, Padilla S, Fernandez-Gonzalez M, Agullo V, Mascarell P, et al.
J Antimicrob Chemother
. 2024 Oct;
80(1):126-137.
PMID: 39450853
Background: The role of integrase strand transfer inhibitors (INSTI) in the cardiovascular risk of people with HIV is controversial. Objectives: To assess the association of INSTI to subclinical atherosclerosis progression...
6.
7.
Gutierrez F, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, Barrajon-Catalan E, Garcia-Abellan J, et al.
Clin Infect Dis
. 2024 Sep;
PMID: 39298641
Background: This study aimed to investigate factors contributing to non-sustained viral suppression, including intermittent viremia and persistent low-level viremia, during cabotegravir (CAB) plus rilpivirine (RPV) long-acting (LA) injectable therapy, with...
8.
Garrido-Rodriguez V, Bulnes-Ramos A, Olivas-Martinez I, Pozo-Balado M, Alvarez-Rios A, Gutierrez F, et al.
J Microbiol Immunol Infect
. 2024 Aug;
57(6):854-867.
PMID: 39209566
Background: Persistence of a low CD4/CD8 ratio is associated with an increased morbimortality in people living with HIV (PLWH) under effective antiretroviral therapy. We aimed to explore the immunological significance...
9.
Gutierrez F, Lopez L, Galera C, Tiraboschi J, Portu J, Garcia-Fraile L, et al.
Clin Infect Dis
. 2024 Jul;
80(2):371-380.
PMID: 38959300
Background: Non-AIDS defining malignancies present a growing challenge for persons with human immunodeficiency virus (HIV, PWH), yet tailored interventions for timely cancer diagnosis are lacking. The Spanish IMPAC-Neo protocol was...
10.
Masia M, Garcia J, Garcia-Abellan J, Padilla S, Fernandez-Gonzalez M, Agullo V, et al.
J Infect Dis
. 2024 May;
PMID: 38743815
Background: The relationship of microbiota composition dynamics and the progression of subclinical atherosclerosis in people with HIV (PWH) remains unknown. Methods: 96-week, prospective, longitudinal study in virologically-suppressed PWH. Carotid intima-media...